Iodine-131—Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study

類似資料

• Thyroid and Hepatic Function After High Dose (131)I-Metaiodobenzylguanidine ((131)I-MIBG) Therapy for Neuroblastoma
  著者:: Quach, Alekist, 等
  出版事項: (2010)
• Comparison of Iodine-123 Metaiodobenzylguanidine (MIBG) Scan and [(18)F]Fluorodeoxyglucose Positron Emission Tomography to Evaluate Response After Iodine-131 MIBG Therapy for Relapsed Neuroblastoma
  著者:: Taggart, Denah R., 等
  出版事項: (2009)
• Phase I Study of Vincristine, Irinotecan, and (131)I-Metaiodobenzylguanidine ((131)I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy (NANT) Trial
  著者:: DuBois, Steven G., 等
  出版事項: (2012)
• Different outcomes for relapsed vs. refractory neuroblastoma after therapy with (131)I-metaiodobenzylguanidine ((131)I-MIBG)
  著者:: Zhou, Margaret J., 等
  出版事項: (2015)
• Phase 1 Study of Vorinostat as a Radiation Sensitizer with (131)I-Metaiodobenzylguanidine ((131)I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma
  著者:: DuBois, Steven G., 等
  出版事項: (2015)